Related content

Adjuvant interferon for early or late recurrence of hepatocellular carcinoma and mortality from hepatocellular carcinoma following curative treatment: A metaanalysis with comparison of different types of hepatitis

By              

Molecular and Clinical Oncology, Vol. 2, Iss. 6, 2014-01 ,pp. : 1125-1134

Spandidos Publications

Access to resources Recommend Favorite

Tumor markers for hepatocellular carcinoma (Review)

By      

Molecular and Clinical Oncology, Vol. 1, Iss. 4, 2013-01 ,pp. : 593-598

Spandidos Publications

Access to resources Recommend Favorite

XAGE1b expression is associated with the diagnosis and early recurrence of hepatocellular carcinoma

By                  

Molecular and Clinical Oncology, Vol. 2, Iss. 6, 2014-01 ,pp. : 1155-1159

Spandidos Publications

Access to resources Recommend Favorite

Expression of Inhibitory Receptors in Natural Killer (CD3^-CD56⁺) Cells and CD3⁺CD56⁺ Cells in the Peripheral Blood Lymphocytes and Tumor Infiltrating Lymphocytes in Patients with Primary Hepatocellular Carcinoma

By Yuen M-F.   Norris S.  

Clinical Immunology, Vol. 101, Iss. 3, 2001-12 ,pp. : 264-269

Academic Press

Access to resources Recommend Favorite

CYLD downregulation is correlated with tumor development in patients with hepatocellular carcinoma

By Kinoshita  

Molecular and Clinical Oncology, Vol. 1, Iss. 2, 2013-01 ,pp. : 309-314

Spandidos Publications

Access to resources Recommend Favorite